Mainstay Medical Announces Regulatory Approval from Australian Therapeutic Goods Administration (TGA) for ReActiv8
(WorldNews Belgium)

Mainstay Medical Announces Regulatory Approval from Australian Therapeutic Goods Administration (TGA) for ReActiv8 06 Dec 2019 08:00 CET Company Name MAINSTAY MEDICAL ISN IE00BJYS1G50 Market Euronext Symbol MSTY Next step is applying for inclusion on Australian Prostheses List for private reimbursement; decision expected in the third quarter of 2020. Regulatory News: Mainstay Medical International plc (`Mainstay` or the `Company`, Euronext Paris: MSTY.PA and Euronext Growth operated by Euronext Dublin (MSTY.IE), today announced that it has received regulatory approval from the Australian Therapeutic Goods Administration (TGA) for ReActiv8, its implantable restorative neurostimulation system...